Matches in SemOpenAlex for { <https://semopenalex.org/work/W3112512651> ?p ?o ?g. }
- W3112512651 abstract "Although the performance of adjuvant chemoradiotherapy (ACRT) for resected gallbladder cancer may improve the survival for certain patients, its impact on the survival in early-stage resected gallbladder adenocarcinoma (GBAC) patients remains underexplored. This study aimed to determine the ACRT effects on the survival of early-stage resected GBAC patients.Patients with early-stage resected GBAC diagnosed between 2010 and 2016 were selected from the Surveillance, Epidemiology, and End Results (SEER) database. The covariables included gender, age, race, tumor differentiation, TNM stage (AJCC TNM staging system, 7th edition), adjuvant radiotherapy (ART), and adjuvant chemotherapy (ACT). The effects of ACRT on survival were evaluated by univariate and multivariate analysis.A total of 1,586 patients with resected GBAC met the inclusion criteria were included in this study. Patients who received ACT were older, with poorer tumor differentiation or higher TNM stage (all p < 0.05), while patients who underwent ART were proved to be significantly correlated with poorer tumor differentiation (p = 0.010) and higher TNM stage (p < 0.001). Univariate and multivariate analysis of overall survival (OS) showed that age (p < 0.001; HR, 2.039; 95% CI, 1.718-2.420), tumor grade (p < 0.001; HR, 1.887; 95% CI, 1.530-2.370), and AJCC 7th TNM stage (p < 0.001; HR, 1.417; 95% CI, 1.182-1.699) were independent prognostic risk factors. Interestingly, ART and ACT were not independently associated with improved OS in the overall cohort analysis. However, when patients were subgrouped according to tumor differentiation, ART (p = 0.049; HR, 0.639; 95% CI, 0.409-0.999) has been identified as a significant prognostic factor for grade III/IV patients. Meanwhile, ARC (p = 0.011; HR, 0.739; 95% CI, 0.586-0.932) was associated with improved OS among tumor stage II patients (p<0.001).ACRT may have specific survival benefits for early-stage resected GBAC patients. ART can improve survival in patients with poor or absent tumor differentiation. Besides, patients with tumor invasion beyond muscularis (stage II tumor) may benefit from ACT. Our study provides supporting evidence for the clinical applications of ACRT in early-stage GBAC patients." @default.
- W3112512651 created "2020-12-21" @default.
- W3112512651 creator A5010479652 @default.
- W3112512651 creator A5020279274 @default.
- W3112512651 creator A5029248441 @default.
- W3112512651 creator A5050419964 @default.
- W3112512651 creator A5087230039 @default.
- W3112512651 date "2020-12-18" @default.
- W3112512651 modified "2023-10-03" @default.
- W3112512651 title "The Efficacy of Adjuvant Chemoradiotherapy in Early-Stage Gallbladder Adenocarcinoma Depends on the Tumor Invasion Depth and Differentiation Level" @default.
- W3112512651 cites W1963593662 @default.
- W3112512651 cites W1974231127 @default.
- W3112512651 cites W1982735995 @default.
- W3112512651 cites W1992550614 @default.
- W3112512651 cites W2042893050 @default.
- W3112512651 cites W2059922433 @default.
- W3112512651 cites W2063945580 @default.
- W3112512651 cites W2078881268 @default.
- W3112512651 cites W2124474327 @default.
- W3112512651 cites W2138428254 @default.
- W3112512651 cites W2143574380 @default.
- W3112512651 cites W2148899606 @default.
- W3112512651 cites W2152111392 @default.
- W3112512651 cites W2274844732 @default.
- W3112512651 cites W2529234593 @default.
- W3112512651 cites W2594402998 @default.
- W3112512651 cites W2803932144 @default.
- W3112512651 cites W2968434663 @default.
- W3112512651 cites W3007519336 @default.
- W3112512651 cites W3046975984 @default.
- W3112512651 doi "https://doi.org/10.3389/fonc.2020.616170" @default.
- W3112512651 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7775593" @default.
- W3112512651 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33392099" @default.
- W3112512651 hasPublicationYear "2020" @default.
- W3112512651 type Work @default.
- W3112512651 sameAs 3112512651 @default.
- W3112512651 citedByCount "1" @default.
- W3112512651 countsByYear W31125126512021 @default.
- W3112512651 crossrefType "journal-article" @default.
- W3112512651 hasAuthorship W3112512651A5010479652 @default.
- W3112512651 hasAuthorship W3112512651A5020279274 @default.
- W3112512651 hasAuthorship W3112512651A5029248441 @default.
- W3112512651 hasAuthorship W3112512651A5050419964 @default.
- W3112512651 hasAuthorship W3112512651A5087230039 @default.
- W3112512651 hasBestOaLocation W31125126511 @default.
- W3112512651 hasConcept C121608353 @default.
- W3112512651 hasConcept C126322002 @default.
- W3112512651 hasConcept C143998085 @default.
- W3112512651 hasConcept C144301174 @default.
- W3112512651 hasConcept C146357865 @default.
- W3112512651 hasConcept C151730666 @default.
- W3112512651 hasConcept C2776534502 @default.
- W3112512651 hasConcept C2777863537 @default.
- W3112512651 hasConcept C2777982462 @default.
- W3112512651 hasConcept C2778424827 @default.
- W3112512651 hasConcept C2780091936 @default.
- W3112512651 hasConcept C2781182431 @default.
- W3112512651 hasConcept C38180746 @default.
- W3112512651 hasConcept C509974204 @default.
- W3112512651 hasConcept C71924100 @default.
- W3112512651 hasConcept C86803240 @default.
- W3112512651 hasConcept C90924648 @default.
- W3112512651 hasConceptScore W3112512651C121608353 @default.
- W3112512651 hasConceptScore W3112512651C126322002 @default.
- W3112512651 hasConceptScore W3112512651C143998085 @default.
- W3112512651 hasConceptScore W3112512651C144301174 @default.
- W3112512651 hasConceptScore W3112512651C146357865 @default.
- W3112512651 hasConceptScore W3112512651C151730666 @default.
- W3112512651 hasConceptScore W3112512651C2776534502 @default.
- W3112512651 hasConceptScore W3112512651C2777863537 @default.
- W3112512651 hasConceptScore W3112512651C2777982462 @default.
- W3112512651 hasConceptScore W3112512651C2778424827 @default.
- W3112512651 hasConceptScore W3112512651C2780091936 @default.
- W3112512651 hasConceptScore W3112512651C2781182431 @default.
- W3112512651 hasConceptScore W3112512651C38180746 @default.
- W3112512651 hasConceptScore W3112512651C509974204 @default.
- W3112512651 hasConceptScore W3112512651C71924100 @default.
- W3112512651 hasConceptScore W3112512651C86803240 @default.
- W3112512651 hasConceptScore W3112512651C90924648 @default.
- W3112512651 hasLocation W31125126511 @default.
- W3112512651 hasLocation W31125126512 @default.
- W3112512651 hasLocation W31125126513 @default.
- W3112512651 hasLocation W31125126514 @default.
- W3112512651 hasLocation W31125126515 @default.
- W3112512651 hasOpenAccess W3112512651 @default.
- W3112512651 hasPrimaryLocation W31125126511 @default.
- W3112512651 hasRelatedWork W1965013348 @default.
- W3112512651 hasRelatedWork W2006351700 @default.
- W3112512651 hasRelatedWork W2111740844 @default.
- W3112512651 hasRelatedWork W2354584592 @default.
- W3112512651 hasRelatedWork W2356484369 @default.
- W3112512651 hasRelatedWork W2363865786 @default.
- W3112512651 hasRelatedWork W2415741046 @default.
- W3112512651 hasRelatedWork W2981648456 @default.
- W3112512651 hasRelatedWork W2782883797 @default.
- W3112512651 hasRelatedWork W3031364695 @default.
- W3112512651 hasVolume "10" @default.
- W3112512651 isParatext "false" @default.
- W3112512651 isRetracted "false" @default.
- W3112512651 magId "3112512651" @default.